BOIRON (EPA:BOI) - Sales in the third quarter of 2023
Transparency directive : regulatory news
(Unaudited data)
SALES IN THE THIRD QUARTER (VARIATION AT CURRENT EXCHANGE RATES)
| In thousands of euros | 1st quarter | 2nd quarter | 3rd quarter | ||||||
| 2023 | 2022 | Var. | 2023 | 2022 | Var. | 2023 | 2022 | Var. | |
| France | 54,580 | 77,055 | -29.2% | 52,277 | 54,283 | -3.7% | 56,005 | 58,275 | -3.9% |
| Europe (excluding France) | 39,220 | 34,476 | +13.8% | 23,656 | 26,228 | -9.8% | 30,561 | 35,744 | -14.5% |
| North America | 33,279 | 28,944 | +15.0% | 24,148 | 23,282 | +3.7% | 28,861 | 29,107 | -0.8% |
| Other countries | 5,220 | 5,305 | -1.6% | 7,504 | 7,189 | +4.4% | 5,683 | 5,295 | +7.3% |
| Group total | 132,299 | 145,780 | -9.2% | 107,585 | 110,982 | -3.1% | 121,110 | 128,422 | -5.7% |
| In thousands of euros | 1st quarter | 2nd quarter | 3rd quarter | ||||||
| 2023 | 2022 | Var. | 2023 | 2022 | Var. | 2023 | 2022 | Var. | |
| Non-proprietary homeopathic medicines | 45,234 | 45,516 | -0.6% | 42,231 | 43,360 | -2.6% | 39,305 | 41,081 | -4.3% |
| Homeopathic specialties | 79,858 | 67,100 | +19.0% | 57,111 | 54,816 | +4.2% | 71,709 | 74,349 | -3.6% |
| Other health products | 7,206 | 33,164 | -78.3% | 8,243 | 12,806 | -35.6% | 10,096 | 12,992 | -22.3% |
| Group total | 132,299 | 145,780 | -9.2% | 107,585 | 110,982 | -3.1% | 121,110 | 128,422 | -5.7% |
Sales in the third quarter of 2023 were down 5.7%. Adjusted for the decline in COVID test sales this comes to 2.8%, exclusively due to the drop-in exchange rates.
The 4.3% decline in non-proprietary homeopathic medicines is still mainly attributable to France.
Sales from homeopathic specialties fell 3.6%, due to lower sales of winter specialties following a warm September.
Sales of other healthcare products continued to decline, due to a decrease in COVID test sales in Europe, particularly in France.
This decline was partially offset by the launch of the CBD by Boiron® range in France, formulated using 98% natural-origin ingredients and comprising three products:
- a cream gel that helps restore joint movement and comfort,
- a gel (tube and roll-on) that helps to reduce tension and relax muscles.
CUMULATIVE SALES AS OF THE END OF SEPTEMBER 2023
| In thousands of euros | 2023 | 2022 | Variation at current exchange rates |
Variation at constant exchange rates |
| France | 162,862 | 189,612 | -14.1% | -14.1% |
| Europe (excluding France) | 93,437 | 96,448 | -3.1% | -0.8% |
| North America | 86,287 | 81,334 | +6.1% | +8.6% |
| Other countries | 18,407 | 17,789 | +3.5% | +3.9% |
| Group total | 360,994 | 385,183 | -6.3% | -5.2% |
| In thousands of euros | 2023 | 2022 | Variation at current exchange rates |
Variation at constant exchange rates |
| Non-proprietary homeopathic medicines | 126,771 | 129,957 | -2.5% | -2.1% |
| Homeopathic specialties | 208,679 | 196,265 | +6.3% | +8.2% |
| Other health products | 25,545 | 58,961 | -56.7% | -56.5% |
| Group total | 360,994 | 385,183 | -6.3% | -5.2% |
Total sales fell 6.3%, impacted by a challenging basis for comparison following significant COVID test sales in France in 2022. Excluding these tests, sales were up 3%.
This growth was achieved in all regions and was driven by sales of homeopathic specialties.
Outlook
The decline in COVID test sales is expected to result in lower revenues in 2023 than in 2022. Excluding test sales, revenues are expected to grow, depending on winter illnesses at the end of the year.
We continue to put all our energy and determination into ensuring that every patient in the world can take advantage of homeopathy and our others healthcare solutions, thereby supporting a more humane, efficient and sustainable healthcare system.
Laboratoires BOIRON
Our next update:January 25, 2024: at market close, publication of the sales for the year 2023.
Person responsible for financial information: Valérie Lorentz-Poinsot
Contact for financial information: Fabrice Rey
Investor relations: +33 (0) 4.37.41.84.01 - e-mail : boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information and the glossary are online at: www.boironfinance.com
- SECURITY MASTER Key: yJlrY8ltZmudnpyaaZdsnJaXam1qx2WXZ2bGk2SZaMubnJ1nl2qWZsaVZnFjmWts
- Check this key: https://www.security-master-key.com.
Regulated information:
Quarterly financial reporting:
- Third quarter financial report
Full and original press release in PDF: https://www.actusnews.com/news/82466-boi-201023-ca-t3-23-gb.pdf